Results 11 to 20 of about 55,585 (143)

Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer’s disease [PDF]

open access: yesNeural Regeneration Research
Stroke and Alzheimer’s disease are common neurological disorders and often occur in the same individuals. The comorbidity of the two neurological disorders represents a grave health threat to older populations.
Shan Ping Yu   +3 more
doaj   +2 more sources

Anti-N-Methyl-d-Aspartate Receptor Encephalitis

open access: yesPediatrics & Neonatology, 2011
Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis is a treatment-responsive encephalitis associated with anti-NMDA receptor antibodies, which bind to the NR1/NR2 heteromers of the NMDA receptors. It is a highly characteristic syndrome evolving in five stages: the prodromal phase (viral infection-like symptoms), psychotic phase, unresponsive phase,
Ning-Hui Foo, Te-Yu Hung, Ming-Chi Lai
openaire   +4 more sources

Anti-N-methyl-D-aspartate receptor encephalitis: analysis of three cases

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2018
Objective To explore the clinical features, diagnosis, treatment and prognosis of patients with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis.
Ya-nan TIAN
doaj   +1 more source

In silico investigation on the probable macromolecular drug targets involved in the anti-schizophrenia activity of Nardostachys jatamansi [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2022
Existing medications i.e. the antipsychotic drugs are known to be effective in treating only the positive symptoms of schizophrenia, while being ineffective on negative and cognitive symptoms of the disease.
Foong Xi Wei   +2 more
doaj   +1 more source

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia

open access: yesnpj Schizophrenia, 2017
The N-methyl-d-aspartate receptor hypofunction is one of the most prevalent models of schizophrenia. For example, healthy subjects treated with uncompetitive N-methyl-d-aspartate receptor antagonists elicit positive, negative, and cognitive-like symptoms
Kazu Nakazawa   +2 more
doaj   +1 more source

Uses of magnesium sulfate in anesthesiology

open access: yesRevista Médica del Hospital General de México, 2022
Introduction: Magnesium sulfate heptahydrate (MgSO4 7H2O) is a divalent cation, pharmacologically its mechanism has been as a reversible blocker of the N-methyl-D-aspartate receptor (NMDAR) and therefore has been proposed in the use of anesthesiology ...
Claudia I. Gutiérrez-Román   +2 more
doaj   +1 more source

Research progress of N⁃methyl⁃D⁃aspartate receptor GRIN2A gene variations and epilepsy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2023
In recent years, with the rapid development of gene sequencing technology, a variety of epilepsy pathogenic genes have been discovered, among which GRIN2A gene variations encoding the neurotransmitter N⁃methyl⁃D⁃aspartate receptor (NMDAR) are closely ...
TANG Wei⁃ting, XIAO Bo
doaj   +1 more source

Long-term potentiation and the role of N -methyl- d -aspartate receptors [PDF]

open access: yesBrain Research, 2015
N-methyl-D-aspartate receptors (NMDARs) are known for their role in the induction of long-term potentiation (LTP). Here we start by reviewing the early evidence for their role in LTP at CA1 synapses in the hippocampus. We then discuss more recent evidence that NMDAR dependent synaptic plasticity at these synapses can be separated into mechanistically ...
Volianskis, Arturas   +5 more
openaire   +5 more sources

N-methyl-D-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-D-aspartate receptor-channel complex. [PDF]

open access: yesProceedings of the National Academy of Sciences, 1989
Kindling is an animal model of epilepsy and neuronal plasticity produced by periodic electrical stimulation of the brain. Electrophysiologic studies indicate that this phenomenon is associated with increased participation of N-methyl-D-aspartate (NMDA) receptors in excitatory synaptic transmission. Biochemical studies suggest that a change intrinsic to
J.V. Nadler   +3 more
openaire   +3 more sources

Development and characterization of functional antibodies targeting NMDA receptors

open access: yesNature Communications, 2022
Selective targeting individual subtypes of N-methyl-D-aspartate receptors (NMDARs) is a desirable therapeutic strategy for neurological disorders.
Nami Tajima   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy